*.- Official Title: A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcoma .
*.- Estimated Enrollment: 60 .
*.- Study Start Date: January 2008 .
*.- Estimated Primary Completion Date: September 2010 (Final data collection date for primary outcome measure) .
*.- Last Updated: April 14, 2010 .
...